Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Life and death of spare (selective bladder preservation against radical excision): reflections on why the spare trial closed.

× No keyword cloud information.

26 in total

1. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

Authors: Raymond H Mak; Daniel Hunt; William U Shipley; Jason A Efstathiou; William J Tester; Michael P Hagan; Donald S Kaufman; Niall M Heney; Anthony L Zietman
Journal: J Clin Oncol Date: 2014-11-03 Impact factor: 44.544

2. Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy.

Authors: Kevin R Kozak; Maryam Hamidi; Matthew Manning; John S Moody
Journal: Int J Radiat Oncol Biol Phys Date: 2012-03-06 Impact factor: 7.038

Review 3. Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.

Authors: Skyler B Johnson; James B Yu
Journal: Curr Oncol Rep Date: 2018-06-30 Impact factor: 5.075

Review 4. [Radiochemotherapy for invasive bladder cancer : An update].

Authors: N Tselis; F J Prott; O Ott; C Weiss; C Rödel
Journal: Urologe A Date: 2018-06 Impact factor: 0.639

5. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.

Authors: Jason A Efstathiou; Kent W Mouw; Ewan A Gibb; Yang Liu; Chin-Lee Wu; Michael R Drumm; Jose Batista da Costa; Marguerite du Plessis; Natalie Q Wang; Elai Davicioni; Felix Y Feng; Roland Seiler; Peter C Black; William U Shipley; David T Miyamoto
Journal: Eur Urol Date: 2019-02-01 Impact factor: 20.096

6. Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT.

Authors: Robert Pickard; Beatriz Goulao; Sonya Carnell; Jing Shen; Graeme MacLennan; John Norrie; Matt Breckons; Luke Vale; Paul Whybrow; Tim Rapley; Rebecca Forbes; Stephanie Currer; Mark Forrest; Jennifer Wilkinson; Elaine McColl; Daniela Andrich; Stewart Barclay; Jonathan Cook; Anthony Mundy; James N'Dow; Stephen Payne; Nick Watkin
Journal: Health Technol Assess Date: 2020-11 Impact factor: 4.014

7. Re: Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy oncology group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

Authors: Sam S Chang
Journal: J Urol Date: 2015-03-13 Impact factor: 7.450

Review 8. Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer.

Authors: James R Broughman; Winston Vuong; Omar Y Mian
Journal: Curr Treat Options Oncol Date: 2020-11-23

9. Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011).

Authors: Sangeetha Paramasivan; Robert Huddart; Emma Hall; Rebecca Lewis; Alison Birtle; Jenny L Donovan
Journal: Trials Date: 2011-03-15 Impact factor: 2.279

10. The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011).

Authors: Clare Moynihan; Rebecca Lewis; Emma Hall; Emma Jones; Alison Birtle; Robert Huddart
Journal: Trials Date: 2012-11-29 Impact factor: 2.279